Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Tech analyst Jukan: Suggests shorting "Pure Fruit Chain" assets, Lingyun Semiconductor becomes the top choice

Tech analyst Jukan: Suggests shorting "Pure Fruit Chain" assets, Lingyun Semiconductor becomes the top choice

格隆汇格隆汇2026/06/28 06:33
Show original
Glonghui June 28th|Citrini Research analyst Jukan posted on the X platform, saying that shorting the Apple supply chain might be an interesting idea. Jukan put forward a reflexive point of view: if Apple's core business remains strong, why are almost all Apple suppliers now doing their utmost to eliminate simple "Apple dependence" and instead desperately trying to move toward the AI concept? This in itself is a reason to be bearish on Apple's business. Jukan noted that there are already very few Apple supply chain stocks on the market that lack AI exposure and rely purely on traditional consumer electronics, and Cirrus Logic (CRUS.US), whose revenue is highly tied to Apple, is one of the few short candidates.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The 160 Threshold Under Threat Again! Yen Nears "Intervention Red Line," Tokyo May Spend Money Again to Rescue the Currency

The Japanese yen is approaching the 1 USD = 160 JPY level. Atsushi Mimura commented that the movement is "too fast." The US-Japan interest rate gap may widen further, and Japanese officials have hinted at being ready to intervene again.

智通财经•2026/11/12 02:26

Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race

Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.

智通财经•2026/11/12 01:07